Search results
Expert view: IPO market may see a stronger pull after the Budget 2024, says Mahavir Lunawat of...
Livemint· 4 days agoExpert view: Mahavir Lunawat, the founder and managing director of Pantomath Financial Services Group, says favourable market conditions, high liquidity, a conducive growth environment with ...
IPO Calendar: Primary market gears up for another robust week as 3 companies look to raise Rs 2,700...
The Economic Times· 6 days agoThe primary market is gearing up for another stellar week as three companies launch their initial...
Lal Sweets looks to raise $40 mn from PE investors at $175 mn valuation
Livemint· 3 days agoThe company, which sells sweets, cookies and savouries, has received a term sheet from the private...
Shark Tank’s Namita Thapar to get Rs 128 crore from Emcure Pharma share sale
Financial Express· 2 days agoNamita Thapar, one of the judges of the famous TV show Shark Tank India will be partially offloading...
Mason Infratech shares list with 37.5% premium at ₹88 apiece on NSE SME | Stock Market News
Livemint· 4 days agoMason Infratech shares were listed at ₹88.00 apiece on NSE SME, a premium of 37.5% to the issue...
Shark Tank fame Namita Thapar likely to make around Rs 127 crore through Emcure Pharmaceuticals IPO...
The Times of India· 4 days agoNamita Thapar, a promoter group member of Emcure Pharmaceuticals and known for her appearance on...
Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of...
The Economic Times· 3 days agoThe initial public offering (IPO) of Emcure Pharmaceuticals will open for subscription on Wednesday,...
Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid? - The Economic Times
The Economic Times· 2 days agoEmcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity...
Mumbai-based Wockhardt to launch its novel antibiotic Zaynich by FY25-end
Business Standard India· 6 days agoIn what could be a major breakthrough for antibiotic research, Mumbai-based Wockhardt is all set to...
Emcure Pharma announces price band for Rs 1,952-crore IPO at Rs 960-1,008/share. Check GMP, other...
The Economic Times· 7 days agoEmcure Pharmaceuticals has set the price band for its upcoming initial public offering (IPO) at Rs...